Completed PHASE4 INTERVENTIONAL 2-arm NCT03513757

Dexmedetomidine and Propofol for Pediatric MRI Sedation

An Observer-blinded Randomized Study of Propofol Infusion vs Bolus Dexmedetomidine and Propofol Sedation for Pediatric Magnetic Resonance Imaging

Sponsor: Medical College of Wisconsin

Conditions Abdominal Neoplasm Headache Hydrocephalus Neurofibromatoses Seizure Disorder Spine Deformity Tumor

Interventions Dexmedetomidine Glycopyrrolate Lidocaine 1% Injectable Solution Nitrous Oxide Sevoflurane propofol

Updated 7 times since 2018 Last updated: Feb 19, 2020 Started: Mar 4, 2018 Primary completion: Aug 21, 2018 Completion: Oct 21, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Abdominal Neoplasm and Headache, this trial is completed. The trial is conducted by Medical College of Wisconsin and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Mar 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Mar 2020 [monthly]

Recruiting PHASE4

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical College of Wisconsin

Data source: Medical College of Wisconsin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milwaukee, United States